Entering text into the input field will update the search result below

Emergent BioSolutions, Inc. (EBS) CEO Bob Kramer on Q1 2020 Results - Earnings Call Transcript

May 02, 2020 12:15 PM ETEmergent BioSolutions Inc. (EBS)
SA Transcripts profile picture
SA Transcripts

Emergent BioSolutions, Inc. (NYSE:EBS) Q1 2020 Results Conference Call April 30, 2020 5:00 PM ET

Company Participants

Bob Burrows - VP, IR

Bob Kramer - President and Chief Executive Officer

Rich Lindahl - Chief Financial Officer

Syed Husain - Senior Vice President and Head of CDMO Business Unit

Laura Saward - Senior Vice President and Head of Therapeutics Business Unit

Conference Call Participants

Brandon Folkes - Cantor Fitzgerald

Jacob Hughes - Wells Fargo

Dana Flanders - Guggenheim

Keay Nakae - Chardan

Jessica Fye - JP Morgan

Boris Peaker - Cowen

Lisa Springer - Singular Research


Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Emergent BioSolutions Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised, today’s conference call maybe recorded. [Operator Instructions].

I would now like to hand the conference over to the company for opening remarks.

Bob Burrows

Thank you, Valerie, and good afternoon, everyone. My name is Bob Burrows. I'm Vice President of Investor Relations for Emergent, and thank you for joining us today as we discuss the operational and financial results for the first quarter of 2020. As is customary, today's call is open to all participants, and in addition, the call is being recorded and is copyrighted by Emergent BioSolutions. The agenda for today's call will be a slight modification to our normal approach.

Participating on the call with prepared comments will be Bob Kramer, President and Chief Executive Officer, and Rich Lindahl, Chief Financial Officer. However, in acknowledgement to recent announcements from the company, in between Bob and Rich will be my colleagues, Syed Husain, Senior Vice President and Head of our CDMO Business Unit, and Dr. Laura Saward, Senior Vice President and Head of our Therapeutics Business Unit. Both will be

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.